The contribution of lysosomotropism to autophagy perturbation

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Ashoor, Roshan ^a   Yafawi, Rolla ^a   Jessen, Bart ^a   Lu, Shuyan ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASTEMIZOLE; CHLOROQUINE; CHLORPROMAZINE; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; GLUTATHIONE TRANSFERASE; IMIPRAMINE; MATRIX PROTEIN; NORTRIPTYLINE; PARAPROTEIN; PAROXETINE; PROTEIN LC3; PROTEIN P62; PROTEIN SQSTM1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SERTRALINE; THIORIDAZINE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; IN VITRO STUDY; LIPOPHILICITY; LYSOSOME; LYSOSOMOTROPISM; PH; PHYSICAL CHEMISTRY; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; UPREGULATION; XENOBIOTIC METABOLISM;

AUTOPHAGY; CELL LINE; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMANS; LYSOSOMES;

EID: 84896696751     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082481     Document Type: Article

References (59)

1. Doria A, Gatto M, Punzi L (2013) Autophagy in human health and disease. N Engl J Med 368: 1845. doi:10.1056/NEJMc1303158. PubMed: 2365665923656658.
2. Chen Y, Yu L (2013) Autophagic lysosome reformation. Exp Cell Res 319: 142-146. doi:10.1016/j.yexcr.2012.09.004. PubMed: 22999865.
3. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H et al. (2004) The role of autophagy during the early neonatal starvation period. Nature 432: 1032-1036. doi:10.1038/nature03029. PubMed: 15525940. (Pubitemid 40052234)
4. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S et al. (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169: 425-434. doi:10.1083/jcb.200412022. PubMed: 15866887. (Pubitemid 40686693)
5. Sou YS, Waguri S, Iwata J, Ueno T, Fujimura T et al. (2008) The Atg8 conjugation system is indispensable for proper development of autophagic isolation membranes in mice. Mol Biol Cell 19: 4762-4775. doi:10.1091/mbc.E08- 03-0309. PubMed: 18768753.
6. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S et al. (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13: 619-624. doi:10.1038/nm1574. PubMed: 17450150. (Pubitemid 46828485)
7. Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11: 709-730. doi:10.1038/nrd3802. PubMed: 22935804.
8. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P et al. (2009) Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLOS ONE 4: e7124. doi:10.1371/journal.pone.0007124. PubMed: 19771169.
9. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A et al. (2007) Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 3: 331-338. doi:10.1038/nchembio883. PubMed: 17486044. (Pubitemid 46789270)
10. Zhang L, Yu J, Pan H, Hu P, Hao Y et al. (2007) Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci U S A 104: 19023-19028. doi:10.1073/pnas.0709695104. PubMed: 18024584.
11. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N et al. (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17: 654-666. doi:10.1158/1078-0432.CCR-10-2634. PubMed: 21325294.
12. Amaravadi RK, Winkler JD (2012) Lys05: a new lysosomal autophagy inhibitor. Autophagy 8: 1383-1384. PubMed: 22878685.
13. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P et al. (1974) Commentary. Lysosomotropic agents. Biochem Pharmacol 23: 2495-2531. doi:10.1016/0006-2952(74)90174-9. PubMed: 4606365.
14. Nadanaciva S, Lu S, Gebhard DF, Jessen BA, Pennie WD et al. (2011) A high content screening assay for identifying lysosomotropic compounds. Toxicol In Vitro 25: 715-723. doi:10.1016/j.tiv.2010.12.010. PubMed: 21184822.
15. Lu S, Jessen B, Strock C, Will Y (2012) The contribution of physicochemical properties to multiple in vitro cytotoxicity endpoints. Toxicol In Vitro 26: 613-620. doi:10.1016/j.tiv.2012.01.025. PubMed: 22342439.
16. Eng CH, Yu K, Lucas J, White E, Abraham RT (2010) Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal 3: ra31. doi:10.1126/scisignal.2000911. PubMed: 20424262.
17. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544. doi:10.4161/auto.19496. PubMed: 22966490.
18. Kostrominova TY, Brooks SV (2013) Age-related changes in structure and extracellular matrix protein expression levels in rat tendons. Age (Dordr).
19. Ihanamäki T, Salminen H, Säämänen AM, Pelliniemi LJ, Hartmann DJ et al. (2001) Age-dependent changes in the expression of matrix components in the mouse eye. Exp Eye Res 72: 423-431. doi:10.1006/ exer.2000.0972. PubMed: 11273670.
20. Pattison JS, Folk LC, Madsen RW, Childs TE, Booth FW (2003) Transcriptional profiling identifies extensive downregulation of extracellular matrix gene expression in sarcopenic rat soleus muscle. Physiol Genomics 15: 34-43. PubMed: 12888627. (Pubitemid 38089551)
21. Qiu H, Tian B, Resuello RG, Natividad FF, Peppas A et al. (2007) Sex-specific regulation of gene expression in the aging monkey aorta. Physiol Genomics 29: 169-180. PubMed: 17456900. (Pubitemid 46701998)
22. Geissler S, Textor M, Kühnisch J, Könnig D, Klein O et al. (2012) Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLOS ONE 7: e52700. doi:10.1371/journal.pone.0052700. PubMed: 23285157.
23. Wang X, Michaelis ML, Michaelis EK (2010) Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability. Curr Genomics 11: 618-633. doi:10.2174/138920210793360943. PubMed: 21629439.
24. Martinez-Vicente M, Sovak G, Cuervo AM (2005) Protein degradation and aging. Exp Gerontol 40: 622-633. doi:10.1016/j.exger.2005.07.005. PubMed: 16125351. (Pubitemid 41265812)
25. Rubinsztein DC, Marino G, Kroemer G (2011) Autophagy and Aging. Cell 146: 682-695.
26. Jeon SH, Kim SH, Kim Y, Kim YS, Lim Y et al. (2011) The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells. Biochem Biophys Res Commun 413: 311-317. doi:10.1016/j.bbrc.2011.08.093. PubMed: 21889492.
27. Cloonan SM, Williams DC (2011) The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma. Int J Cancer 128: 1712-1723. doi:10.1002/ijc.25477. PubMed: 20503272.
28. Shin SY, Lee KS, Choi YK, Lim HJ, Lee HG et al. (2013) The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis, 34: 2080-9. PubMed: 23689352.
29. Myers BM, Tietz PS, Tarara JE, LaRusso NF (1995) Dynamic measurements of the acute and chronic effects of lysosomotropic agents on hepatocyte lysosomal pH using flow cytometry. Hepatology 22: 1519-1526. doi:10.1002/hep.1840220527. PubMed: 7590671.
30. Ndolo RA, Forrest ML, Krise JP (2010) The role of lysosomes in limiting drug toxicity in mice. J Pharmacol Exp Ther 333: 120-128. doi:10.1124/jpet.109. 160226. PubMed: 20056778.
31. Kawai A, Uchiyama H, Takano S, Nakamura N, Ohkuma S (2007) Autophagosome-lysosome fusion depends on the pH in acidic compartments in CHO cells. Autophagy 3: 154-157. PubMed: 17204842. (Pubitemid 46449110)
32. Iwai-Kanai E, Yuan H, Huang C, Sayen MR, Perry-Garza CN et al. (2008) A method to measure cardiac autophagic flux in vivo. Autophagy 4: 322-329. PubMed: 18216495. (Pubitemid 351458093)
33. Gräbner R (1987) Influence of cationic amphiphilic drugs on the phosphatidylcholine hydrolysis by phospholipase A2. Biochem Pharmacol 36: 1063-1067. doi:10.1016/0006-2952(87)90415-1. PubMed: 3566802.
34. Kubo M, Hostetler KY (1985) Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1. Biochemistry 24: 6515-6520. doi:10.1021/bi00344a031. PubMed: 4084534. (Pubitemid 16207124)
35. Elojeimy S, Holman DH, Liu X, El-Zawahry A, Villani M et al. (2006) New insights on the use of desipramine as an inhibitor for acid ceramidase. FEBS Lett 580: 4751-4756. doi:10.1016/j.febslet.2006.07.071. PubMed: 16901483. (Pubitemid 44189397)
36. Ikeda K, Hirayama M, Hirota Y, Asa E, Seki J et al. (2008) Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes. Biochem Biophys Res Commun 377: 268-274. doi:10.1016/j.bbrc.2008.09.121. PubMed: 18840403.
37. Boya P (2012) Lysosomal function and dysfunction: mechanism and disease. Antioxid Redox Signal 17: 766-774. doi:10.1089/ars.2011.4405. PubMed: 22098160.
38. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383-1435. doi:10.1152/physrev.00030.2009. PubMed: 20959619.
39. Nixon RA, Yang DS, Lee JH (2008) Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4: 590-599. PubMed: 18497567.
40. Mannerström M, Mäenpää H, Toimela T, Salminen L, Tähti H (2001) The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures. Pharmacol Toxicol 88: 27-33. doi:10.1034/j.1600-0773.2001.088001027.x. PubMed: 11169158.
41. Chen CL, Hou WH, Liu IH, Hsiao G, Huang SS et al. (2009) Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses. J Cell Sci 122: 1863-1871. doi:10.1242/jcs.038729. PubMed: 19461075.
42. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39: D1035-1041.
43. de Medina P, Silvente-Poirot S, Poirot M (2009) Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation. Autophagy 5: 1066-1067. doi:10.4161/auto.5. 7.9820. PubMed: 19738414.
44. Zschocke J, Zimmermann N, Berning B, Ganal V, Holsboer F et al. (2011) Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons - dissociation from cholesterol homeostasis. Neuropsychopharmacology 36: 1754-1768. doi:10.1038/npp.2011.57. PubMed: 21508931.
45. Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC (2010) Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 285: 11061-11067. doi:10.1074/jbc.R109. 072181. PubMed: 20147746.
46. Bharadwaj PR, Verdile G, Barr RK, Gupta V, Steele JW et al. (2012) Latrepirdine (Dimebon) enhances autophagy and reduces intracellular GFP-Abeta42 levels in yeast. J Alzheimers Dis 32: 949-967. PubMed: 22903131.
47. CSID:24605987, Available online at: http://www.chemspider.com/Chemical- Structure.24605987.html. Accessed: 2013 August 14
48. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S et al. (2012) A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31: 1095-1108. doi:10.1038/ emboj.2012.32. PubMed: 22343943.
49. Hopkins CR (2010) ACS chemical neuroscience molecule spotlight on Dimebon. ACS Chem Neurosci 1: 587-588. doi:10.1021/cn1000588. PubMed: 22778847.
50. Bezprozvanny I (2010) The rise and fall of Dimebon. Drug News Perspect 23: 518-523. PubMed: 21031168.
51. HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network (2013) A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. JAMA Neurol 70: 25-33. doi: 10.1001/2013.jamaneurol.382. PubMed: 23108692.
52. Boya P, Kroemer G (2008) Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434-6451. doi:10.1038/onc.2008.310. PubMed: 18955971.
53. Aits S, Jäättelä M (2013) Lysosomal cell death at a glance. J Cell Sci 126: 1905-1912. doi:10.1242/jcs.091181. PubMed: 23720375.
54. Hu W, Lu S, McAlpine I, Jamieson JD, Lee DU et al. (2012) Mechanistic investigation of imatinib-induced cardiac toxicity and the involvement of c-Abl kinase. Toxicol Sci 129: 188-199. doi:10.1093/ toxsci/kfs192. PubMed: 22641616.
55. Moscat J, Diaz-Meco MT (2012) p62: a versatile multitasker takes on cancer. Trends Biochem Sci 37: 230-236. doi:10.1016/j.tibs. 2012.02.008. PubMed: 22424619.
56. Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T et al. (2010) A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 30: 3275-3285. doi:10.1128/MCB.00248-10. PubMed: 20421418.
57. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A et al. (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213-223. PubMed: 20173742.
58. Lau A, Zheng Y, Tao S, Wang H, Whitman SA et al. (2013) Arsenic inhibits autophagic flux, activating the Nrf2-Keap1 pathway in a p62- dependent manner. Mol Cell Biol 33: 2436-2446. doi:10.1128/MCB. 01748-12. PubMed: 23589329.
59. Kitareewan S, Roebuck BD, Demidenko E, Sloboda RD, Dmitrovsky E (2007) Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia. J Natl Cancer Inst 99: 41-52. doi:10.1093/jnci/ djk004. PubMed: 17202112.